Novo Nordisk has presented new findings from its phase 3 Evoke and Evoke+ trials on using semaglutide as part of Alzheimer’s ...

Avalere Health, a global strategic partner for the healthcare industry, has announced the appointment of Sarah Hall as its ...

The US, EU and UK operate under different systems, with distinct expectations for clinical evidence, timelines and commercial ...

Exhibitions remain one of the most powerful ways for pharmaceutical and life sciences organisations to connect, educate and ...

Kite, a Gilead Company, has presented new findings demonstrating the safety, efficacy and quality of life benefits offered by ...

Pfizer has announced results from its phase 3 BASIS study of Hympavzi (marstacimab), demonstrating its success in reducing ...

Embodiment Perhaps more philosophical, but none-the less highly relevant, is the concept of embodiment – the experience of ...

Our 2025 EcoVadis reassessment has resulted in a score of 75/100, allowing us to maintain our silver medal status for the 3rd year running. This achievement places us in the top 15% of all companies ...

As global pricing reforms squeeze margins and reshapes supply chains, manufacturers can restore confidence through smarter ...

NRG Therapeutics has appointed Paul Thompson as its new Chief Development Officer, who brings specialist expertise in ...

New results from the phase 1 VNA-318-01 human study have shown favourable safety and tolerability, with the data showing that ...

AI-generated personas can assist in brainstorming with a hypothetical HCP, validate test queries for medical information ...